| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Selenoproteins | 6 | 2024 | 159 | 3.170 |
Why?
|
| T-Lymphocytes | 5 | 2022 | 357 | 2.150 |
Why?
|
| Osteoarthritis | 3 | 2021 | 20 | 2.020 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 4 | 2020 | 9 | 1.710 |
Why?
|
| Lymphocyte Activation | 3 | 2024 | 236 | 1.680 |
Why?
|
| Ethanolamine | 2 | 2021 | 8 | 1.570 |
Why?
|
| Phospholipids | 2 | 2021 | 70 | 1.490 |
Why?
|
| Chondrocytes | 3 | 2021 | 16 | 1.130 |
Why?
|
| Cell Differentiation | 3 | 2024 | 587 | 1.070 |
Why?
|
| DNA-Activated Protein Kinase | 2 | 2015 | 4 | 0.970 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2015 | 52 | 0.950 |
Why?
|
| Immunoglobulin M | 1 | 2024 | 82 | 0.940 |
Why?
|
| Dendritic Cells | 2 | 2015 | 113 | 0.900 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 185 | 0.900 |
Why?
|
| Lipopolysaccharides | 2 | 2024 | 220 | 0.880 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2022 | 6 | 0.860 |
Why?
|
| Mice, Knockout | 8 | 2024 | 933 | 0.840 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2020 | 172 | 0.830 |
Why?
|
| Selenium | 2 | 2021 | 148 | 0.810 |
Why?
|
| Ethanolaminephosphotransferase | 1 | 2021 | 4 | 0.810 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 2 | 2018 | 10 | 0.810 |
Why?
|
| DNA Damage | 3 | 2020 | 352 | 0.780 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2018 | 5 | 0.770 |
Why?
|
| Metabolism | 1 | 2020 | 9 | 0.760 |
Why?
|
| Genomic Instability | 1 | 2020 | 38 | 0.740 |
Why?
|
| Mice | 14 | 2024 | 5913 | 0.710 |
Why?
|
| Signal Transduction | 10 | 2019 | 1908 | 0.690 |
Why?
|
| Up-Regulation | 4 | 2024 | 513 | 0.650 |
Why?
|
| Oxidative Stress | 3 | 2021 | 938 | 0.640 |
Why?
|
| Hyperhomocysteinemia | 1 | 2018 | 4 | 0.630 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2015 | 10 | 0.630 |
Why?
|
| Sirtuin 1 | 1 | 2018 | 32 | 0.620 |
Why?
|
| Polyadenylation | 1 | 2018 | 49 | 0.610 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 14 | 0.610 |
Why?
|
| Proteins | 1 | 2020 | 369 | 0.610 |
Why?
|
| Protein Kinases | 1 | 2018 | 100 | 0.600 |
Why?
|
| Inflammation | 3 | 2021 | 618 | 0.590 |
Why?
|
| Interleukin-12 | 2 | 2015 | 47 | 0.570 |
Why?
|
| Interleukin-6 | 2 | 2015 | 153 | 0.540 |
Why?
|
| Interferon Type I | 1 | 2015 | 18 | 0.510 |
Why?
|
| DNA Methylation | 1 | 2018 | 325 | 0.510 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 1609 | 0.500 |
Why?
|
| Animals | 16 | 2024 | 15081 | 0.500 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 628 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 807 | 0.460 |
Why?
|
| Phosphatidylethanolamines | 3 | 2024 | 27 | 0.450 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2013 | 5 | 0.450 |
Why?
|
| Neoplasms | 2 | 2018 | 1103 | 0.390 |
Why?
|
| Cells, Cultured | 4 | 2021 | 1518 | 0.380 |
Why?
|
| Humans | 19 | 2024 | 37093 | 0.350 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 1371 | 0.340 |
Why?
|
| Metabolomics | 2 | 2021 | 81 | 0.340 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 1502 | 0.310 |
Why?
|
| Cyclooxygenase 2 | 4 | 2019 | 104 | 0.310 |
Why?
|
| Phosphorylation | 3 | 2017 | 928 | 0.310 |
Why?
|
| Fanconi Anemia | 2 | 2017 | 12 | 0.310 |
Why?
|
| MAP Kinase Signaling System | 3 | 2022 | 169 | 0.290 |
Why?
|
| Protein Binding | 3 | 2020 | 972 | 0.280 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1198 | 0.250 |
Why?
|
| Plasma Cells | 1 | 2024 | 10 | 0.250 |
Why?
|
| Oligodendroglia | 1 | 2024 | 24 | 0.240 |
Why?
|
| Myelin Sheath | 1 | 2024 | 48 | 0.230 |
Why?
|
| Pseudoxanthoma Elasticum | 1 | 2024 | 32 | 0.230 |
Why?
|
| Mitochondria | 2 | 2018 | 487 | 0.230 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2024 | 48 | 0.230 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2020 | 42 | 0.220 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 119 | 0.220 |
Why?
|
| Apoptosis | 2 | 2021 | 1398 | 0.220 |
Why?
|
| Homeostasis | 1 | 2024 | 188 | 0.210 |
Why?
|
| NF-kappa B | 2 | 2017 | 339 | 0.210 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2012 | 32 | 0.210 |
Why?
|
| Interleukin-17 | 1 | 2022 | 53 | 0.210 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 76 | 0.200 |
Why?
|
| Galectin 3 | 1 | 2021 | 26 | 0.200 |
Why?
|
| Interferon-alpha | 2 | 2012 | 43 | 0.200 |
Why?
|
| Galectins | 1 | 2021 | 28 | 0.200 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 461 | 0.200 |
Why?
|
| Blood Proteins | 1 | 2021 | 66 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 62 | 0.200 |
Why?
|
| Selenocysteine | 1 | 2021 | 55 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2015 | 269 | 0.190 |
Why?
|
| Ethanolamines | 1 | 2021 | 12 | 0.190 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2021 | 21 | 0.190 |
Why?
|
| Lipogenesis | 1 | 2021 | 18 | 0.190 |
Why?
|
| Protein Stability | 1 | 2020 | 45 | 0.190 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 67 | 0.190 |
Why?
|
| Glycolysis | 1 | 2021 | 68 | 0.190 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 145 | 0.180 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 117 | 0.180 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 190 | 0.180 |
Why?
|
| STAT1 Transcription Factor | 3 | 2015 | 35 | 0.180 |
Why?
|
| Phenotype | 1 | 2022 | 689 | 0.170 |
Why?
|
| Matrix Metalloproteinases | 1 | 2019 | 48 | 0.170 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2019 | 15 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 356 | 0.170 |
Why?
|
| Chromosomal Instability | 1 | 2018 | 22 | 0.160 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2018 | 3 | 0.160 |
Why?
|
| RNA Interference | 2 | 2017 | 243 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 123 | 0.160 |
Why?
|
| Colitis | 1 | 2019 | 65 | 0.160 |
Why?
|
| Homocysteine | 1 | 2018 | 19 | 0.160 |
Why?
|
| Models, Genetic | 1 | 2018 | 172 | 0.160 |
Why?
|
| Cartilage, Articular | 1 | 2017 | 9 | 0.150 |
Why?
|
| Time Factors | 2 | 2020 | 1742 | 0.150 |
Why?
|
| Poly I-C | 1 | 2017 | 7 | 0.150 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2017 | 7 | 0.150 |
Why?
|
| PPAR gamma | 1 | 2018 | 53 | 0.150 |
Why?
|
| Histones | 1 | 2018 | 190 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 93 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 186 | 0.140 |
Why?
|
| Protein Kinase C | 1 | 2017 | 120 | 0.140 |
Why?
|
| Mutation | 2 | 2018 | 1095 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 196 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2022 | 426 | 0.140 |
Why?
|
| Energy Metabolism | 1 | 2017 | 168 | 0.140 |
Why?
|
| DNA Repair | 1 | 2017 | 188 | 0.130 |
Why?
|
| Female | 6 | 2024 | 20969 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 1015 | 0.130 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2015 | 6 | 0.130 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2015 | 7 | 0.130 |
Why?
|
| Antigens, Nuclear | 1 | 2015 | 6 | 0.130 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 16 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 54 | 0.120 |
Why?
|
| Serotonin | 2 | 2012 | 123 | 0.120 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2013 | 5 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 131 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2013 | 176 | 0.110 |
Why?
|
| Fluoxetine | 1 | 2012 | 11 | 0.110 |
Why?
|
| Enzyme Activators | 1 | 2012 | 12 | 0.110 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 14 | 0.110 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2011 | 10 | 0.100 |
Why?
|
| STAT Transcription Factors | 1 | 2011 | 12 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2013 | 399 | 0.100 |
Why?
|
| RNA, Small Interfering | 3 | 2022 | 409 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 448 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 539 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 121 | 0.100 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2010 | 8 | 0.100 |
Why?
|
| Male | 5 | 2024 | 20025 | 0.100 |
Why?
|
| Nerve Growth Factor | 1 | 2010 | 30 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2022 | 435 | 0.080 |
Why?
|
| Macrophages | 1 | 2012 | 439 | 0.080 |
Why?
|
| Recombinant Proteins | 3 | 2017 | 515 | 0.080 |
Why?
|
| Asthma | 1 | 2010 | 380 | 0.070 |
Why?
|
| Plasmalogens | 1 | 2024 | 4 | 0.060 |
Why?
|
| Phospholipid Ethers | 1 | 2024 | 6 | 0.060 |
Why?
|
| Lymphangiogenesis | 1 | 2024 | 4 | 0.060 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2024 | 11 | 0.060 |
Why?
|
| Lymphatic Vessels | 1 | 2024 | 6 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2024 | 37 | 0.060 |
Why?
|
| Vibrissae | 1 | 2024 | 33 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2024 | 140 | 0.060 |
Why?
|
| Calcinosis | 1 | 2024 | 59 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 1 | 2022 | 29 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2022 | 14 | 0.050 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2022 | 28 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 105 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2012 | 79 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 55 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 74 | 0.050 |
Why?
|
| Autophagy | 1 | 2022 | 116 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 2231 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 194 | 0.050 |
Why?
|
| Tendinopathy | 1 | 2019 | 1 | 0.040 |
Why?
|
| Silicon Dioxide | 1 | 2019 | 34 | 0.040 |
Why?
|
| Interleukin-16 | 1 | 2019 | 5 | 0.040 |
Why?
|
| Antibodies | 1 | 2019 | 141 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 60 | 0.040 |
Why?
|
| Actins | 1 | 2019 | 148 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 139 | 0.040 |
Why?
|
| Reference Values | 1 | 2019 | 212 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 89 | 0.040 |
Why?
|
| Cell Line | 2 | 2012 | 1354 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2018 | 325 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2017 | 35 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 562 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 265 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 893 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2017 | 216 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 173 | 0.030 |
Why?
|
| Brain | 1 | 2024 | 1346 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 651 | 0.030 |
Why?
|
| Depression | 2 | 2012 | 712 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1618 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 1180 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 674 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2012 | 17 | 0.030 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2012 | 14 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2012 | 63 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 2012 | 46 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 115 | 0.030 |
Why?
|
| Rats | 1 | 2019 | 3483 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 103 | 0.030 |
Why?
|
| STAT2 Transcription Factor | 1 | 2011 | 2 | 0.030 |
Why?
|
| Biological Transport | 1 | 2012 | 185 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 99 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 122 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 302 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 444 | 0.020 |
Why?
|
| 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1 | 2010 | 2 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 523 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2010 | 56 | 0.020 |
Why?
|
| Allergens | 1 | 2010 | 63 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2012 | 316 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 433 | 0.020 |
Why?
|
| Calcium | 1 | 2012 | 480 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 859 | 0.020 |
Why?
|
| Lung | 1 | 2010 | 446 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2010 | 384 | 0.020 |
Why?
|